Medicine and Dentistry
Patient
100%
Allogeneic Hematopoietic Stem Cell Transplantation
83%
Transplantation
66%
Cyclophosphamide
66%
Peripheral Blood Stem Cell Transplantation
66%
Mortality
50%
Reduced Intensity Conditioning
50%
Engraftment
50%
Chronic Graft Versus Host Disease
50%
Busulfan
50%
Overall Survival
33%
Inpatient
16%
Incidence
16%
Donor
16%
Neutrophil
16%
Mortality Rate
16%
Survival Rate
16%
Recurrence Free Survival
16%
Cumulative Incidence
16%
Acute Graft Versus Host Disease
16%
Spontaneous Remission
16%
Disease Free Survival
16%
Subgroup Analysis
16%
Immunology and Microbiology
Allogeneic Hematopoietic Stem Cell Transplantation
83%
Transplantation
66%
Cyclophosphamide
66%
Mortality
50%
Chronic Graft Versus Host Disease
50%
Engraftment
50%
Incidence
33%
Conditioning
33%
Overall Survival
33%
Neutrophil Granulocyte
16%
Acute Graft Versus Host Disease
16%
Survival Rate
16%
Recurrence Free Survival
16%
Mortality Rate
16%
Disease Free Survival
16%